01.07.2003 | Invited Commentary
Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: Rationale and options
Erschienen in: Current Hypertension Reports | Ausgabe 4/2003
Einloggen, um Zugang zu erhalten